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Abstract: In the rapid development of nanoscience and nanotechnology, many researchers have 
discovered that metal oxide nanoparticles have very useful pharmacological effects. Cuprous 
oxide nanoparticles (CONPs) can selectively induce apoptosis and suppress the proliferation of 
tumor cells, showing great potential as a clinical cancer therapy. Treatment with CONPs caused 
a G1/G0 cell cycle arrest in tumor cells. Furthermore, CONPs enclosed in vesicles entered, or 
were taken up by mitochondria, which damaged their membranes, thereby inducing apoptosis. 
CONPs can also produce reactive oxygen species (ROS) and initiate lipid peroxidation of the 
liposomal membrane, thereby regulating many signaling pathways and influencing the vital 
movements of cells. Our results demonstrate that CONPs have selective cytotoxicity towards 
tumor cells, and indicate that CONPs might be a potential nanomedicine for cancer therapy.
Keywords: nanomedicine, selective cytotoxicity, apoptosis, cell cycle arrest, mitochondrion-
targeted nanomaterials
Introduction
Nanoscience and nanotechnology have advanced greatly in recent years, and a large 
amount of research has focused on determining the properties and potential functions 
of nanomaterials.1–3 Nanomaterials show many unique and useful properties and can be 
applied in the areas of medicine, biology, and life science research.4–8 Nanomaterials 
have distinct magnetic properties, a large surface-to-volume ratio, and fluorescence, 
among others. They play important roles, such as developers, drug carriers, and 
tracers.9–14 Research has also shown that nanoparticles can affect the functions of cells 
and biomolecules. Nanomaterials can be toxic to cells and harmful to humans and 
other organisms. Many papers have reported that ZnO, TiO2, Ag, iron core-gold shell 
nanoparticles, and Au nanorods15–18 can specifically induce the apoptosis of tumor 
cells. These results agree well with the idea in traditional Chinese medicine (TCM) that 
“poisonous drugs sometimes can be used to treat serious and stubborn diseases.” The 
TCM text, Shen Nong’s Herbal, describes a medicine containing azurite ore, a copper 
mineral that has potential antitumor properties. Arsenic trioxide, another traditional 
Chinese medicine, has the same antitumor property, and it has been used to treat acute 
promyelocytic leukemia successfully.19–21 Although Shen Nong’s Herbal describes both 
as cancer agents, azurite ore, in particular, shows poor solubility in water, making 
it difficult to investigate its antitumor property directly. However, nanoscience and 
nanotechnology methods offer a chance to solve this challenging issue.
CONPs are a new type of p-type semiconductor, have active electron-cavity pairs 
and good catalytic activity, and have been extensively applied in various fields, such 
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as electrochemistry and physics.22–26 However, only a few 
studies have focused on the biological effects of CONPs, 
which are important in understanding the biological   activity 
of nanomaterials. CONPs containing copper might also have 
pharmacological functions similar to those of azurite ore. 
  Furthermore, cuprous oxide can bind to the hydrosulfide 
group, as arsenic trioxide does. We predict that CONPs may 
show therapeutic efficacy against cancer. However, the poten-
tial anticancer properties of CONPs remain an undeveloped 
area that is of medical interest.
In this study, we prepared CONPs to explore their phar-
macological effects on cancerous HeLa cells, melanoma cells 
YUMAC, normal human 293T cells, and mouse embryonic 
fibroblast (MEF) cells. We discover that CONPs could 
selectively induce apoptosis and suppress the proliferation 
of tumor cells. From the transmission electron microscopy 
images, we found that CONPs could target the mitochondria 
and cause damage to their membranes. Furthermore, we car-
ried out lipid peroxidation measurements and a dithiothreitol 
(DTT) protection experiment to test the effects of ROS on 
apoptosis. Our data show that CONPs have the potential for 
use in anticancer therapy.
Material and methods
Preparation of CONPs
All of the chemical reagents used in this experiment were 
of analytical grade. CONPs were synthesized as follows: 
First, 0.35 mL of 0.1 M CuSO4 (aq) was added to 3 mL of 
0.1 M cetyltrimethylammonium bromide (CTAB) (aq) in a 
test tube, and the solutions were allowed to mix for about 
5 minutes. Then, 10 mL of fresh, chilled 0.04 M NaBH4 
(aq) was added to the mixture. The mixture was stirred 
at 26°C–28°C. After approximately 18 hours, the mixture 
turned yellow. Finally, the product was harvested from the 
solution by centrifugation at 12,000 rpm for 15–20 minutes 
and washed several times with ethanol and deionized water. 
After removing the supernatant, the product was dried in a 
vacuum dryer for 12–18 hours at 50°C. The dried product 
was stored in a hermetic container at 4°C.22,27
Characterization of CONPs
The prepared CONPs were characterized by powder X-ray 
diffraction (XRD) and transmission electron microscopy 
(TEM). The XRD pattern was obtained using a D/MAX-
rB  X-ray powder diffractometer (Rigaku, Japan) using Cu 
Ka radiation (average wavelength is 0.15418 nm), and the 
operation voltage and current were maintained at 30 kV and 
30 mA, respectively. The morphologies of the CONPs were 
examined by TEM at an acceleration voltage of 100 kV. 
Dynamic light scattering size analyses of CONPs in suspen-
sions was carried out using a Nano HT Zetasizer (Malvern 
Instruments, Malvern, UK). The UV-visible spectra of the 
dispersions were obtained with a visible/UV-spectrophotom-
eter (UV2450, Shimadu, Japan). Fourier transform infrared 
(FTIR) spectra of the samples were recorded using an Alpha-
T spectrometer (Nicolet Nexus470, Nicolet, USA).
Cytotoxicity assay
The HeLa cells, 293T cells, and MEF cells used in this 
research were grown in Dulbecco’s modified Eagle’s medium 
(DMEM), and the melanoma cell line YUMAC were grown 
in Opti-MEM (Gibco™, Invitrogen Corp, Calsbad, CA). 
Both mediums were supplemented with 2 mg/mL sodium 
bicarbonate, 4.5 mg/mL glucose, 100 µg/mL streptomycin 
sulfate, 40 µg/mL gentamicin, 100 U/mL penicillin. DMEM 
were supplemented with 10% (vol/vol) heat-inactivated fetal 
calf serum, and the Opti-MEM were 5%. An environment of 
humidified air containing 5% CO2 was maintained at 37°C. 
HeLa cells, 293T cells, and melanoma cell line YUMAC 
were stored by our laboratory. The original source of the 
HeLa cells and 293T cells was the Cell Bank of Typical 
Culture Collection (Chinese Academy of Sciences,   Shanghai, 
China). The YUMAC cells were provided generously by 
Yale University School of Medicine (New Haven, CT). 
The MEF cells were obtained from day 13 C57BL/6 mouse 
embryos. To evaluate the cytotoxicity of the CONPs, cells in 
the log phase were seeded onto a 96-well culture plate with 
2000 cells per well and incubated at 37°C in a CO2 incuba-
tor for 24 hours until the cells adhered to the plate. Serial 
dilutions of CONPs were added, and after 48 hours, cell 
viability was measured using the 3-(4,5-di-methylthiazol-
2yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. For 
this assay, 200 µL of 5 mg/mL MTT solution (prepared in 
medium without blood serum) was added to the cells in the 
culture and incubated at 37°C in a CO2 incubator for 4 hours. 
Dimethyl sulfoxide was then used to dissolve the formazan 
crystals. Finally, the absorbance was measured at 570 nm 
using an ELISA plate reader.28
Apoptosis detection by Annexin V 
staining
Cells in the log phase were seeded onto a 6-well culture 
plate at a density of 1 × 105 cells per well and incubated 
at 37°C in a CO2 incubator in the presence of CONPs. The 
cells were treated with 0, 10, or 20 µg/mL CONPs. After 
48 hours, apoptosis and necrosis were analyzed with the 
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Annexin V-fluorescein isothiocyanate apoptosis detection 
kit 1 following the manufacturer’s instructions. The samples 
were analyzed using a BD FACSCanto instrument (BD 
Biosciences, Franklin Lakes, NJ).
Flow cytometry of cell cycle progression
The cells were harvested using 0.25% trypsin with 1 mM 
of EDTA solution and fixed for 12 hours in 70% ethanol at 
4°C. The fixed cells were then centrifuged at 3000 rpm for 
15 minutes to remove the ethanol thoroughly. The cells were 
then washed twice with 3 mL of phosphate-buffered saline 
(PBS), resuspended in 1 mL of propidium iodide (PI) staining 
  solution, and incubated for 15 minutes at room   temperature. 
The staining solution consisted of 20 µg/mL PI and 0.2 mg/mL 
RNase A in PBS. The samples were subsequently analyzed 
using a BD FACSCanto instrument (BD Biosciences, Franklin 
Lakes, NJ).
Transmission electron microscopy (TEM) 
assay
The HeLa cells were grown in a large petri dish. When cells 
had adhered to the dish, a solution of CONPs was added to 
a final concentration of 30 µg/mL. The cells were incubated 
at 37°C in a CO2 incubator. After approximately 4 hours, the 
cells were harvested, washed twice with PBS, and incubated 
with 4°C formaldehyde overnight to fix the cells. The cells 
were then dehydrated with increasing concentrations of etha-
nol (50%, 60%, 70%, 80%, 90%, and 100%) for 15 minutes 
each, stained with 2% uranyl acetate in 70% ethanol over-
night at room temperature, and then embedded in Epon. The 
embedded samples were sectioned into 60-nm-thick slices 
using a sliding ultramicrotome. Thin sections supported by 
copper grids were examined using a Hitachi TEM system 
operated at 100 kV (Hitachi, Tokyo, Japan).
Dithiothreitol protection experiment
ROS may play an important role in lipid peroxidation and the 
suppression of cell growth. Dithiothreitol (DTT) is a hypotoxic 
reducing agent that can inactivate ROS and protect the hydro-
sulfide groups of protein. The cells were cultured as described 
above in the cytotoxicity assay section, except 20 µg/mL of 
fresh DTT was added to the cell medium or lipid peroxidation 
reaction mixture. After 48 hours, an MTT assay was used to 
determine the extent of the protective effects of DTT.
Lipid peroxidation measurement
The free-radical modulation activity of CONPs was 
determined using a lipid peroxidation assay. Briefly, lipid 
peroxidation was induced in liposomes prepared from 
soybean lecithin and cholesterol by ultrasonic irradiation. 
The CONPs were added to the prepared liposomes and the 
control samples were supplemented with PBS. The samples 
were incubated at 37°C for 1 hour in a dark incubator. The 
reaction was inhibited by adding an equal volume of stop 
solution (0.25 M HCl, 1.5% (wt/vol) trichloroacetic acid, and 
0.375% (wt/vol) thiobarbituric acid). These reaction mixtures 
were boiled for 15 minutes, cooled, and then centrifuged at 
12,000 rpm for 15 minutes. The absorbance of the resulting 
solution was measured at 532 nm.15,28
Statistical analysis
Data were analyzed using SigmaPlot 10.0 software (Systat 
Software Inc, San Jose, CA). Statistical differences between 
the control and treatment groups for the in vitro experiments 
comparing the toxicity of the CONPs were determined using 
an analysis of paired t-test with significance set at P , 0.05.
Results and discussion
Characterization of CONPs
The XRD patterns (Figure 1) showed that the CONPs were 
crystalline, and the diffraction pattern and interplanar spacing 
of the CONPs were similar to those in the standard diffraction 
pattern of cuprous oxide.22 Furthermore, no characteristic 
peaks of impurities were detected, suggesting that high-
quality CONPs were obtained. The UV-vis spectrum of the 
CONPs showed a wide absorption band between 200 nm 
and 500 nm (Figure 2). Figure 3 presents the FTIR spectra 
of the CONPs, showing their composition and quality. The 
band at 624 cm–1 correlates with the stretching vibrations of 
cuprous oxide. The bands at approximately 2922 cm–1 and 
1373 cm–1 are probably due to the carbonate moieties, water, 
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Figure 1 X-ray patterns of the CONPs.
Note: Results revealed the crystal structure of the CONPs, and no characteristic 
peaks of impurities were detected.
Abbreviation: CONPs, cuprous oxide nanoparticles.
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Figure 2 UV-vis spectra of the CONPs.
Note: CONPs were dissolved in deionized water and deionized water was used 
as a reference.
Abbreviation: CONPs, cuprous oxide nanoparticles.
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Figure 3 FTIR transmission spectra of the CONPs. The band at 624 cm–1 correlates to the stretching vibration of the CONPs.
Notes: Moreover, there were also some stretching bands. The other bands at 3398 cm–1, 2992 cm–1, 1373 cm–1, and 839 cm–1 are probably due to the carbonate moieties 
and water that are generally observed, when FTIR samples are measured in air.
Abbreviations: CONPs, cuprous oxide nanoparticles; FTIR, Fourier transform-infrared.
or other organic compounds in the air that were adsorbed by 
the CONPs, as these bands are generally observed when FTIR 
samples are measured in air.15 The TEM images showed that 
the CONPs were all spherical and homogeneous (Figure 4). 
The diameter of the CONPs in the suspensions ranged from 
approximately 40 nm to 110 nm (Figure S1). From our 
characterization of the CONPs, we can see that the CONPs 
prepared in our experiment were of good quality.
Cytotoxicity assay
In TCM, copper or cuprous compounds have been used 
to treat cancer and other diseases for thousands of years.29 
These cuprous compounds may have properties similar to 
those of another effective antitumor drug, arsenic trioxide.19–21 
Copper is a known heavy metal that is toxic to human cells 
and has been shown to have significant side effects on the 
human body. However, with the development of nanoscience 
and nanotechnology, research has shown that nanoparticles 
can target specific organs, have a lower toxicity against 
the whole organism, and have good dissolubility in water. 
Therefore, CONPs may be an ideal combination of TCM 
and nanoscience. Despite the strong potential of CONPs to 
be a novel therapy tool, no study has reported on the interac-
tions of CONPs in the relevant in vitro or in vivo biological 
settings.
To solve this fundamental issue and to investigate the 
potential uses of CONPs as cancer therapeutics, an MTT 
assay was used to evaluate how CONPs affect the viability of 
HeLa cells and melanoma cells with normal human 293T cells 
and MEF cells as control. CONPs exhibited dose-dependent 
cytotoxicity in HeLa cells with a half-maximal inhibitory 
concentration (IC50) of 8.28 µg/mL, and in melanoma cells 
with IC50 of 1.533 µg/mL, whereas the IC50 values in MEF 
cells and 293T cells were 27.00 µg/mL and 14.22 µg/mL, 
respectively. The cancerous HeLa cells and melanoma 
cells displayed a strikingly greater sensitivity to the CONPs 
than the normal human (293T) or mouse (MEF) cell lines 
did (P , 0.005) (Figure 5). At low concentrations, lower 
than 5 µg/mL, there was a discriminative difference in the 
level of cytotoxicity between tumor cells and normal cells. 
  Differential cytotoxicity is important because one of the 
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greatest   challenges facing chemotherapy is the inability of 
anticancer drugs to distinguish effectively between tumor 
cells and normal cells. In our study, low concentrations of 
CONPs selectively killed tumor cells, suggesting that CONPs 
may be useful as a potential anticancer drug. In addition 
to CONPs, ZnO nanoparticles also have selective toxicity 
against human myeloblastic leukemia cells (HL60) and show 
less toxicity against normal peripheral blood mononuclear 
cells.15 Therefore, CONPs may have a potential utility in 
the treatment of cancer, as do ZnO nanoparticles. Research 
has also shown that iron core-gold shell NPs have cancer 
cell-specific cytotoxicity.16 Referring to the periodic table of 
elements, it is not difficult to understand these results. Zn(II) 
and Cu(I) have a similar extranuclear electron assignment, 
which may contribute to their similar properties. Therefore, 
we can conjecture that the chemical and physical properties 
of these nanomedicines provide the basis of their biological 
action. Furthermore, some research has reported that the tumor 
cells were unable to clear the nanoparticles, but this result was 
different in the normal cells.30 In our experiment, the inability 
to clear CONPs might be one of the mechanisms that caused 
CONPs to show selective cytotoxicity against tumor cells.
100 nm 0.2 µm
0.1 µm 0.1 µm
Figure 4 TEM images of the CONPs.
Note: The CONPs were all perfect spheres, and the mixtures were homogeneous.
Abbreviations: CONPs, cuprous oxide nanoparticles; TEM, transmission electron microscopy.
Apoptosis and cell cycle progression
Several studies have indicated that different nanoparticles 
can suppress cell viability by different mechanisms. Specific 
kinds of nanoparticles can induce apoptosis in cells, but other 
kinds of nanoparticles can make cells undergo necrosis.15,16,31 
To investigate the mechanism of CONPs cytotoxicity, we 
performed flow cytometry to analyze the effects of CONPs 
on cell death and cell cycle. First, Annexin V- and PI-based 
apoptosis and necrosis discrimination assays were performed 
on HeLa and MEF cells exposed to 10 µg/mL and 20 µg/mL 
of CONPs for 48 hours (Figure 6). The results showed an 
increase in apoptosis in HeLa cells, which was dependent on 
the dose of CONPs, and a similar increase in necrosis was 
observed. However, decreased apoptosis and necrosis were 
observed in the MEF cells in accordance with the cytotoxic-
ity assays. These results showed that CONPs have selective 
antitumor properties.
Apoptosis is a cell suicide mechanism that enables 
organisms to control cell numbers and to eliminate cells 
that threaten survival. The apoptotic cascade can be trig-
gered through two major pathways. Extracellular signals, 
such as members of the tumor necrosis factor (TNF) family 
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Figure 5 Differential cytotoxicity of CONPs on tumor cell (melanoma cells YUMAC), paired control tumor cell (HeLa), and normal cells (293T and MEF) detected by MTT assay.
Notes: HeLa cells and melanoma cells were more sensitive, and the two normal cell lines (293T and MEF cells) were tolerant, especially at low concentrations. Cells were 
treated with the CONPs for 48 hours (*P , 0.005, n = 3).
Abbreviations: CONPs, cuprous oxide nanoparticles; MEF, mouse embryonic fibroblast.
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Figure 6 Flow cytometry analysis of HeLa and MEF cells treated with different concentrations of CONPs for 48 hours and then stained with Annexin V and PI.
Notes: Significant increases in apoptosis were observed in HeLa cells exposed to the 10 µg/mL and 20 µg/mL CONPs for 48 hours. However, decreased apoptosis was 
observed in the MEF cells. The upper-left quadrant in each panel shows the necrotic population, the upper-right quadrant shows the late apoptotic population, and the lower-
right quadrant shows the early apoptotic population.
Abbreviations: CONPs, cuprous oxide nanoparticles; MEF, mouse embryonic fibroblast; PI, propidium iodine.
or the Fas/FasL pathway, can activate the receptor-mediated 
extrinsic pathway. Alternatively, stress signals, such as 
DNA damage, hypoxia, and loss-of-survival signals, may 
trigger the mitochondrial intrinsic pathway.32,33 CONPs 
are p-type semiconductors and have active electron-cavity 
pairs. CONPs can produce ROS, break disulfide bonds, and 
bind to the hydrosulfide group in proteins. Because of their 
fundamental chemical and physical properties, CONPs 
could exert oxidative stress on cells and cause membrane 
damage and DNA breaks. Because many proteins in the 
cell contain disulfide bonds or hydrosulfide groups, CONPs 
may target these proteins and influence their activity, thus 
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regulating tumor-specific signal pathways, exhibiting 
specific pharmacological activity, or inducing the apop-
tosis of tumor cells, which were similar to the effects of 
arsenic trioxide. Moreover, cellular respiration is the basis 
of every vital movement in the cell. The electron transport 
chain performs an important role in cellular respiration 
and contains several protein complexes that have cuprous 
active centers. CONPs may also release cuprous ions and 
influence the electron transfer through the respiratory 
chain, causing tumor cells to lack energy and start the 
apoptotic pathway.
Cell cycle progression analysis was performed and 
showed that HeLa cells were arrested strongly by CONPs 
in a dose-dependent manner. Approximately 58% of cells 
exposed to 10 µg/mL of CONPs and 80% of cells exposed 
to 20 µg/mL of CONPs were arrested in G1/G0 48 hours 
after CONPs exposure (Figure 7). Furthermore, the number 
of cells in S phase decreased as the concentration of CONPs 
increased. However, the iron-core gold-shell nanoparticles 
also suppressed cell proliferation and cells were delayed in 
S phase,16 whereas the cells exposed to CONPs were delayed 
in G1/G0. Furthermore, treatment with Ag nanoparticles 
caused a cell cycle arrest in G2/M phase, possibly due to 
the repair of damaged DNA.34 These results show that dif-
ferent nanoparticles have different effects on the cell cycle, 
which may be important in exploring the mechanism of their 
biological actions.
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Figure 7 Cell cycle progression assay of HeLa cells treated with different concentrations of CONPs for 48 hours.
Notes: Proliferation of HeLa cells was strongly suppressed by CONPs in a dose-dependent manner. Cells were arrested in the G1/G0 phase after 48 hours of treatment 
and were less able to proliferate.
Abbreviation: CONPs, cuprous oxide nanoparticles.
Our experimental data show that CONPs also suppressed 
the proliferation of tumor cells and caused a cell cycle 
arrest in G1/G0. These effects showed that CONPs might 
inhibit DNA replication. DNA replication relies on many 
factors, including the DNA replication machinery, cyclin/
cyclin-dependent kinase (CDK) complexes, the production 
of anti-oncogenes (such as p53), growth factor-mediated 
cellular signaling, and others. CONPs may influence one or 
more of these factors to suppress DNA replication. CONPs 
are a novel type of p-type semiconductor that have active 
electron-cavity pairs and could produce ROS that upregulate 
p53-mediated cellular signaling, which may be a mechanism 
by which the cells are arrested in the G1/G0 phase.35 From the 
similar properties of cuprousion, we could infer that CONPs 
may also break disulfide bonds and bind to hydrosulfide 
groups. Because numerous proteins contain disulfide bonds 
and hydrosulfide groups, these proteins may be targets of 
the CONPs, which could explain how the CONPs influenced 
cell signaling. Moreover, disulfide bonds and hydrosulfide 
groups are also located on the cell membrane; therefore, 
CONPs might bind to the cell membrane and imitate contact 
inhibition to suppress cell proliferation.
Transmission electron microscopy assay
To determine the mechanism of apoptosis, it is essential 
to know whether the CONPs crossed the cell membrane. 
We therefore used TEM to analyze HeLa cells that had been 
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treated with 30 µg/mL CONPs for 3–4 hours. As shown in Fig-
ure 8(A), we observed that several CONPs were enclosed in 
small vesicles within the cells. In addition, numerous CONPs 
were found in the cytoplasm. The CONPs in the cytoplasm 
had two possible sources. First, the CONPs may have pen-
etrated the cell membrane without breaking it. Alternatively, 
the CONPs were taken up by cells in small vesicles, but then 
they broke the membrane of the vesicles and were released 
into the cytoplasm. Furthermore, all the images showed that 
CONPs could not efficiently enter the nucleus, lysosomes, 
or endoplasmic reticulum. However, the CONPs could cause 
endoplasmic reticulum tumescence (Figure 8B).
It is important to note that the CONPs within the vesicles 
could target the mitochondria, enter the mitochondria, and 
cause their rupture (Figure 8E and F). How could the CONPs 
within the vesicles target the mitochondria? Referring to the 
TEM images, the whole process might be described as fol-
lows: The CONPs, which may adsorb the serum proteins in 
the medium, were taken up by the cells, which was mediated 
by special receptors and resulted in CONPs entering the cell 
in small vesicles. The vesicles containing the CONPs may 
express special proteins, which could bind to the mitochon-
drial outer membrane, that were transported in the cytoplasm 
and targeted the mitochondria. The membranes of the vesicles 
and the mitochondria would then fuse, and the CONPs would 
be released into the mitochondria. As we discussed   previously, 
CONPs can produce ROS and may bind to proteins with 
hydrosulfide groups. The membrane of the mitochondria 
was broken by the CONPs immediately afterwards. Tumor 
cells may lose the ability to clear the nanoparticles that had 
been taken up by these cells. However, normal cells can 
clear the nanoparticles efficiently,30 and were resistant to 
the CONPs. The CONPs were therefore selectively toxic to 
the tumor cells and targeted the mitochondria.   Alternatively, 
Figure 8A, C and D show that the outer membrane of the 
mitochondria invaginated at the surface touching the vesicles 
containing CONPs and pseudopodium-like structures, which 
might take up the vesicles and is similar to cell   phagocytosis. 
Thereby, the phagocytosis of mitochondria might be observed 
in our TEM images, and the vesicles were actively taken up 
by the mitochondria. Further studies should be performed to 
determine the mechanism by which the CONPs entered the 
mitochondria.
Similarly, gold nanorods bound to CTAB could also tar-
get the mitochondria of tumor cells. However, gold nanorods 
bound to CTAB targeted the mitochondria without vesicles.30 
AC B
DF E
Figure 8 Transmission electron images of HeLa cells treated with a solution of CONPs (30 µg/mL) for 4 hours. The arrows indicate the accumulation of the CONPs. (A) The 
CONPs entered a mitochondrion and broke its outer membrane. CONPs existed in vesicles and in the cytoplasm. (B) The endoplasmic reticulum swelled visibly. A structure 
similar to an autophagy body phagocytized a group of CONPs. (C) The vesicles containing the CONPs appeared to target the outer membrane of the mitochondrion, and 
the shape of the mitochondrion had changed. (D) CONPs localized in small vesicles and entered or were entering the mitochondrion. (E and F) CONPs broke the membrane 
of the mitochondrion and caused structural changes.
Abbreviations: CONPs, cuprous oxide nanoparticles; M, mitochondrion; ER, endoplasmic reticulum.
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Mitochondrial damage resulted in cytochrome C release 
and the formation of the apoptosome, a multimeric protein 
complex containing Apaf-1, cytochrome C, and caspase-9, 
which initiates the apoptotic pathway. Furthermore, damag-
ing the mitochondria would result in a lack of energy and 
could lead to cell death.
Our research shows that CONPs could target the mito-
chondria and have selective toxicity against tumor cells. The 
inability to clear the CONPs might be one of the mechanisms 
to induce apoptosis of tumor cells selectively.
Dithiothreitol protection experiment  
and lipid peroxidation measurement
ROS have a very close relationship with various vital move-
ments and participate in immunological and pathological 
reactions, cell injury and death, and tumor generation. Recent 
researches have shown that metal oxide nanoparticles 
can exhibit spontaneous or light-activated ROS produc-
tion, depending on the material composition and surface 
characteristics.15,36 To determine the role of ROS in cell death, 
DTT protection experiments and lipid peroxidation measure-
ments were performed. DTT is commonly used in biochemical 
studies to prevent the oxidation of thiol groups and to reduce 
disulfides to dithiols, which can inactivate ROS.37–39 Our study 
results show that DTT could significantly prevent the cyto-
toxicity observed in cells treated with low concentrations of 
CONPs. However, DTT was unable to prevent significantly 
the cytotoxicity observed at higher concentrations (P , 0.01) 
(Figure 9). These studies indicate that the pharmacological 
actions of CONPs might result from the generation of ROS, 
which in turn are responsible for inducing apoptosis.
To highlight ROS production, we performed lipid peroxi-
dation experiments. The oxidation of fatty acids leads to the 
generation of lipid peroxides, thereby initiating a chain reac-
tion that results in the disruption of the plasma and organelle 
membranes and subsequent cell death. Lipid peroxidation 
experiments show that DTT effectively inhibited the gen-
eration of the lipid peroxidation product malondialdehyde 
(MDA). MDA could be observed at low levels only when 
a concentration of greater than 20 µg/mL CONPs was used 
(Figure 10). However, higher levels of MDA were observed 
when DTT was not in the reaction mixture.
ROS can result in oxidative stress to cells, modulate the 
ability of thioredoxin (TRX) to interact and inhibit ASK1, 
and upregulate the JNK-, p38-, and p53-mediated signal-
ing pathways, resulting in damaged lipids, proteins, DNA 
and other cellular components.6 Oxidative modifications 
of redox-sensitive transcription factors, including NF-κB 
and HIF-1α, and intermediate signaling molecules, such as 
PKC, ERK, JNK, and MAPKs, have also been shown to be 
involved in the ROS-mediated modulation of cell growth and 
survival.38,40 CONPs could induce the production of ROS and 
influence the vital movements of the cell. ROS were most 
likely involved in the apoptosis of tumor cells.
Conclusion
We investigated the selective cytotoxicity of CONPs on 
cancerous cells. CONPs can effectively induce apoptosis 
and suppress the cell cycle progression of tumor cells. By 
using TEM, we found that the CONPs could enter cells and 
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Figure 9 DTT protection experiment on HeLa cells for 48 hours. The MTT assay 
was then performed to evaluate protective effects of DTT. 
Notes: The results show that DTT could increase cell viability at low concentrations 
but reduced viability at higher concentrations (P , 0.01, n = 3).
Abbreviations: CONPs, cuprous oxide nanoparticles; DTT, dithiothreitol; MTT, 
3-(4,5-di-methylthiazol-2yl)-2,5-diphenyl tetrazolium bromide.
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Figure 10 Lipid peroxidation measurement of CONPs in the liposomes prepared 
from soybean lecithin and cholesterol. 
Notes: CONPs increased the lipid peroxidation activity and produced ROS, but 
DTT could significantly block the generation of ROS (P , 0.01, n = 3).
Abbreviations: CONPs, cuprous oxide nanoparticles; DTT, dithiothreitol; ROS, 
reactive oxygen species.
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specifically target the mitochondria, which may be one of the 
mechanisms by which CONPs induced apoptosis. We also 
examined the generation of ROS after treatment with CONPs 
and the effects of ROS on apoptosis using DTT protection and 
lipid peroxidation assays. The results indicate that CONPs 
could induce ROS production and increase lipid peroxidation. 
These changes might influence many cell signaling pathways 
and initiate apoptotic pathways.
Our work showed the potential utility of CONPs for 
the treatment of cancer owing to the selective toxicity of 
CONPs against tumor cells. However, further studies should 
be performed to learn more about the properties of these 
nanoparticles.
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Figure S1 Hydrodynamic size distributions of CONPs in water. 
Note: The diameter of the CONPs ranged from approximately 40 nm to 110 nm.
Abbreviation: CONPs, cuprous oxide nanoparticles.
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